Sign in
Taking peopleNo phase

Sleep, meal timing and glucose monitoring in early pregnancy and gestational diabetes

Tests wearable self-monitoring of sleep, meals and glucose in pregnant women without diabetes.

Key facts

Who runs it
KK Women's and Children's Hospital
Where
Singapore1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
Status
Recruiting
People taking part
140 people, planned
Started
1 May 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Continuous glucose monitor (CGM)
  • Wrist actigraphy device
  • AI-based dietary and meal timing logging mobile application
Record updated
15 September 2026

Who can take part

The trial is looking for women in early pregnancy, without diabetes, who are already in the TOFFFY study. It looks at how sleep, activity and meal timing relate to blood sugar.

Age
21 Years to 39 Years
Sex
Female only
Disease stage
A healthy pregnancy growing inside the womb, at ≤13 weeks of pregnancy at enrolment. Only one baby.
Earlier treatment
People taking medicines known to strongly affect blood sugar cannot join.
Main reasons for not taking part
  • Diabetes before pregnancy (Type 1 or Type 2)
  • Long-term health problems that affect blood sugar
  • Taking medicines known to strongly affect blood sugar
  • Pregnancy with twins or more babies
  • Unable to use smartphone apps or wear a wrist activity device

This trial only enrols pregnant participants. The registry sentence this rests on: * Females who are currently pregnant and with viable intrauterine pregnancy at ≤13 weeks gestation at enrolment

Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Enrolled in the Towards Optimal Fertility, Fathering and Fatherhood studY (TOFFFY) (NCT06293235)
  • Females who are currently pregnant and with viable intrauterine pregnancy at ≤13 weeks gestation at enrolment

Who cannot take part

  • Females with pre-existing diabetes mellitus (Type 1 or Type 2) and/or chronic medical conditions affecting glucose metabolism
  • Females who are taking medications known to significantly affect glucose metabolism
  • Females with multiple pregnancy (e.g., twins or higher-order gestation)
  • Females who are unable to comply with study procedures, including: Inability to use smartphone-based applications and inability to wear wrist actigraphy device

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex

This trial is currently available in Singapore.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to examine how daily behavioral patterns in early pregnancy, including sleep, physical activity, and meal timing, influence continuous glucose dynamics and subsequent risk of gestational diabetes mellitus (GDM) in pregnant women without pre-existing diabetes.

Read full original descriptionShow less

The main questions it aims to answer are:

1. Do early-pregnancy chronobehavioral patterns (e.g., irregular sleep, night eating, and unstable rest-activity rhythms) relate to continuous glucose patterns measured using continuous glucose monitoring (CGM)? 2. Can early behavioral and CGM-derived measures predict glucose regulation and metabolic outcomes later in pregnancy (24-28 weeks)? 3. Does real-time self-monitoring using wearable devices and food logging improve glycemic outcomes compared to usual care?

This study is a prospective, nested randomized pilot trial embedded within the ongoing Towards Optimal Fertility, Fathering and Fatherhood studY (TOFFFY) cohort (NCT06293235) at KK Women's and Children's Hospital, Singapore. A total of 140 pregnant women without pre-existing diabetes, recruited at ≤13 weeks gestation, will be randomized in a 1:1 ratio to either a pilot arm (wearable-based self-monitoring) or a control arm (usual care).

Participants in the pilot arm (n=70) will undergo intensive behavioral and metabolic monitoring over a 14-day period in early pregnancy, including continuous glucose monitoring using a CGM device, wrist actigraphy to assess sleep-wake and rest-activity patterns, and an AI-supported mobile application to record meal timing and dietary intake. Participants will have real-time access to their glucose data and behavioral feedback, enabling self-monitoring and potential behavioral adjustments.

The 2 groups in the trial

  • Pilot armTreatment being tested

    Participants in this arm (n=70) will undergo a 14-day monitoring period in early pregnancy (≤13 weeks gestation). Participants will have real-time access to their glucose data and food logging feedback, enabling self-monitoring and potential behavioural adjustments. Participants will also continue to receive routine antenatal care and standard clinical assessments.

    Treatment: Continuous glucose monitor (CGM), Wrist actigraphy device, and AI-based dietary and meal timing logging mobile application

  • Control ArmNo study treatment, for comparison

    Participants (n=70) receive routine antenatal care only, with no additional devices, monitoring, or feedback introduced by the study.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early-Pregnancy Chronobehavioural Profiles and Continuous Glucose Dynamics: A Nested Randomised Pilot Study of TOFFFY
Plain-language title
Sleep, meal timing and glucose monitoring in early pregnancy and gestational diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07534670, who can take part
Record updated
15 September 2026